Fel-O-Vax Lv-K IV + CaliciVax

This page contains information on Fel-O-Vax Lv-K IV + CaliciVax for veterinary use.
The information provided typically includes the following:
  • Fel-O-Vax Lv-K IV + CaliciVax Indications
  • Warnings and cautions for Fel-O-Vax Lv-K IV + CaliciVax
  • Direction and dosage information for Fel-O-Vax Lv-K IV + CaliciVax

Fel-O-Vax Lv-K IV + CaliciVax

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine

Killed Virus, Killed Chlamydia

For Veterinary Use Only

For subcutaneous vaccination of healthy cats 8 to 10 weeks of age or older, as an aid in the prevention of disease caused by feline leukemia, rhinotracheitis, calici, panleukopenia viruses and as an aid in the reduction of the severity of disease due to feline Chlamydia psittaci. The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to protect vaccinated cats against calicivirus-induced hemorrhagic disease in controlled vaccination challenge experiments.

Dose: Inject one 1 mL dose subcutaneously using aseptic technique. Repeat in 3 to 4 weeks. Annual revaccination with a single dose of vaccine is recommended.

The PEEL-OFF LABEL I.D. SYSTEM provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.

For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal’s medical chart.

Using the System:

1.

Grasp the vial label at the corner marked with an indicator arrow, between your thumb and forefinger (figure 1).

2.

Pull steadily at a slight angle until the label is separated from the vial (figure 2).

3.

Place the label on the animal’s medical chart. Press down on the label to ensure adhesion.

Fel-O-Vax Lv-K IV + CaliciVax Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.

Fel-O-Vax Lv-K IV + CaliciVax Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

U.S. Patent Nos. 6,042,835; 7,264,816; 7,306,807; 7,309,495; 7,449,323 used under license

Fel-O-Vax Lv-K® and CaliciVax® are registered trademarks of Boehringer Ingelheim Vetmedica, Inc.

© 2011 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

U.S. Veterinary License No. 124

50 Doses:

50 - 1 mL Vials of Vaccine

10411

D18296C

NAC No.: 10282561

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.productionvalues.us
    www.prrsresearch.com
    www.thinkmetacam.com
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the Fel-O-Vax Lv-K IV + CaliciVax information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)